NPP
IBB icon

New Potomac Partners’s iShares Biotechnology ETF IBB Stock Holding History

New Potomac Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$467K Sell
3,210
-150
-4% -$21.7K 0.24% 68
2024
Q2 		$461K Sell
3,360
-100
-3% -$13.3K 0.25% 70
2024
Q1 		$475K Hold
3,460
– – 0.26% 68
2023
Q4 		$470K Hold
3,460
– – 0.28% 70
2023
Q3 		$423K Sell
3,460
-60
-2% -$7.63K 0.29% 65
2023
Q2 		$447K Sell
3,520
-200
-5% -$26K 0.29% 63
2023
Q1 		$480K Hold
3,720
– – 0.33% 61
2022
Q4 		$488K Buy
3,720
+40
+1% +$5.17K 0.36% 59
2022
Q3 		$430K Sell
3,680
-29
-0.8% -$3.6K 0.36% 54
2022
Q2 		$436K Sell
3,709
-100
-3% -$11.9K 0.35% 53
2022
Q1 		$496K Hold
3,809
– – 0.35% 51
2021
Q4 		$581K Hold
3,809
– – 0.38% 50
2021
Q3 		$616K Sell
3,809
-325
-8% -$54.7K 0.43% 49
2021
Q2 		$677K Hold
4,134
– – 0.46% 49
2021
Q1 		$622K Sell
4,134
-1
-0% -$159 0.46% 52
2020
Q4 		$626K Sell
4,135
-385
-9% -$55K 0.45% 52
2020
Q3 		$612K Sell
4,520
-60
-1% -$8.14K 0.49% 50
2020
Q2 		$626K Hold
4,580
– – 0.56% 49
2020
Q1 		$493K Sell
4,580
-1,555
-25% -$179K 0.54% 48
2019
Q4 		$739K Sell
6,135
-1,240
-17% -$138K 0.69% 46
2019
Q3 		$734K Sell
7,375
-190
-3% -$19.9K 0.73% 48
2019
Q2 		$825K Sell
7,565
-490
-6% -$52.1K 0.84% 45
2019
Q1 		$901K Sell
8,055
-290
-3% -$31.8K 0.91% 44
2018
Q4 		$805K Buy
8,345
+380
+5% +$40.3K 0.87% 43
2018
Q3 		$971K Sell
7,965
-200
-2% -$23.6K 0.9% 43
2018
Q2 		$897K Sell
8,165
-173
-2% -$18.5K 0.87% 42
2018
Q1 		$890K Sell
8,338
-115
-1% -$12.7K 0.87% 43
2017
Q4 		$903K Buy
+8,453
New +$904K 0.86% 44

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

New Potomac Partners's IBB Position: Q3 2024 in Review

New Potomac Partners reduced its iShares Biotechnology ETF (IBB) stake by 4.5% in Q3 2024, selling an estimated $21.7K and leaving 3,210 shares worth $467K. The position accounts for 0.24% of the portfolio, ranked #68.

New Potomac Partners first reported a position in IBB in Q4 2017 and has held it in 28 quarters since. The position peaked at $971K in Q3 2018. 895 funds tracked by Wall St. Rank hold IBB as of Q3 2024.

  • New Potomac Partners held 3,210 shares of iShares Biotechnology ETF worth $467K as of Q3 2024.
  • New Potomac Partners sold 150 iShares Biotechnology ETF shares in Q3 2024, an estimated $21.7K.
  • iShares Biotechnology ETF made up 0.24% of New Potomac Partners's portfolio in Q3 2024, its #68 holding.
  • New Potomac Partners first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 28 quarters since.
  • New Potomac Partners's iShares Biotechnology ETF position peaked at $971K in Q3 2018.
  • 895 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.

Based on New Potomac Partners's 13F filing for Q3 2024, filed 8 Nov 2024.